The extent of cardiac damage before transcatheter aortic valve implantation significantly impacts smartwatch-recorded physical activity both at baseline and following the intervention.
Does the extent of extravalvular cardiac damage affect smartwatch-recorded physical activity before and after TAVI in patients with severe symptomatic aortic stenosis?
85 patients with severe symptomatic aortic stenosis undergoing transcatheter aortic valve implantation (TAVI), dichotomized into cardiac damage stages 0-2 (n=43) and stages 3-4 (n=42).
Transcatheter aortic valve implantation (TAVI) with 7 days of continuous Fitbit smartwatch monitoring before the procedure and at 6-month follow-up.
Cardiac damage stages 0-2 (left-heart dysfunction) versus stages 3-4 (pulmonary/right-heart dysfunction).
Total daily step count and moderate to vigorous physical activity (MVPA) at baseline and 6-month follow-up.patient reported
Advanced extravalvular cardiac damage (stages 3-4) in severe aortic stenosis is associated with lower baseline physical activity and less improvement following TAVI compared to earlier stages.
Background: Wearable smartwatches enable objective quantification of physical activity. This study evaluated the association of extravalvular cardiac damage in aortic stenosis with smartwatch‐recorded physical activity before and after transcatheter aortic valve implantation (TAVI). Methods: Patients with severe symptomatic aortic stenosis were dichotomized into cardiac damage stages 0 to 2 (left‐heart dysfunction) and stages 3 to 4 (pulmonary/right‐heart dysfunction) by echocardiography. All patients received a Fitbit smartwatch for 7 days of continuous monitoring before transcatheter aortic valve implantation and at 6‐month follow‐up. Regression models determined significant predictors of total daily step count and moderate to vigorous physical activity (MVPA). Results: Within the study cohort (stages 0–2: 43 50.6%; stages 3–4: 42 49.4%), all patients showed significant improvement in physical activity from baseline to follow‐up (all P <0.001). Patients in stages 3 to 4 had significantly lower total daily step count and MVPA at baseline and follow‐up, as well as a smaller improvement in MVPA (all P <0.05). Relative to stages 0 to 2, stages 3 to 4 were significantly associated with lower step count and MVPA at baseline (step count: β=−1453.8 95% CI, −2351.3 to −554.2, P =0.002; MVPA: β=−12.9 95% CI, −24.3 to −1.5, P =0.027) and follow‐up (step count: β=−1438.1 95% CI, −2453.9 to −422.3, P =0.006; MVPA: β=−27.4 95% CI, −47.7 to −7.1, P =0.009), as well as less improvement in MVPA (β=−14.5 95% CI, −28.4 to −0.48, P =0.043) after transcatheter aortic valve implantation. Conclusions: The extent of cardiac damage before transcatheter aortic valve implantation has an important impact on physical activity, both at baseline and following intervention. Future studies should examine whether smartwatch‐measured activity predicts death across cardiac damage stages and whether cardiac rehabilitation improves outcomes in aortic stenosis with advanced remodeling.
Building similarity graph...
Analyzing shared references across papers
Loading...
Vitaliy Androshchuk
Edouard Long
Omar Chehab
Journal of the American Heart Association
King's College London
St Thomas' Hospital
St. Thomas Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Androshchuk et al. (Tue,) reported a other. The extent of cardiac damage before transcatheter aortic valve implantation significantly impacts smartwatch-recorded physical activity both at baseline and following the intervention.
www.synapsesocial.com/papers/69d893c96c1944d70ce04c07 — DOI: https://doi.org/10.1161/jaha.125.047277